NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
4.420
-0.080 (-1.78%)
At close: Sep 16, 2025, 4:00 PM EDT
4.520
+0.100 (2.26%)
Pre-market: Sep 17, 2025, 5:21 AM EDT
NuCana Market Cap
NuCana has a market cap or net worth of $8.43 million as of September 17, 2025. Its market cap has decreased by -51.43% in one year.
Market Cap
8.43M
Enterprise Value
-2.92M
1-Year Change
-51.43%
Ranking
Category
Stock Price
$4.42
Market Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $490.64M to $8.43M, a decrease of -98.28%. That is a compound annual growth rate of -39.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 8.43M | 80.56% |
| Dec 31, 2024 | 4.67M | -69.80% |
| Dec 29, 2023 | 15.47M | -54.67% |
| Dec 30, 2022 | 34.12M | -72.26% |
| Dec 31, 2021 | 123.00M | -45.94% |
| Dec 31, 2020 | 227.51M | 16.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |